Nisa Investment Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.2M | Sell |
13,447
-4,095
| -23% | -$630K | 0.01% | 589 |
|
|
2025
Q4 | $3.05M | Buy |
17,542
+7,076
| +68% | +$1.29M | 0.01% | 521 |
|
|
2025
Q3 | $1.51M | Buy |
10,466
+8,261
| +375% | +$1.01M | 0.01% | 720 |
|
|
2025
Q2 | $222K | Sell |
2,205
-1,556
| -41% | -$119K | ﹤0.01% | 1194 |
|
|
2025
Q1 | $287K | Buy |
3,761
+228
| +6% | +$17.4K | ﹤0.01% | 1140 |
|
|
2024
Q4 | $244K | Buy |
3,533
+183
| +5% | +$13.2K | ﹤0.01% | 1236 |
|
|
2024
Q3 | $245K | Buy |
3,350
+1,572
| +88% | +$116K | ﹤0.01% | 1231 |
|
|
2024
Q2 | $119K | Buy |
1,778
+135
| +8% | +$5.24K | ﹤0.01% | 1428 |
|
|
2024
Q1 | $44.6K | Buy |
1,643
+118
| +8% | +$3.3K | ﹤0.01% | 1685 |
|
|
2023
Q4 | $47.3K | Sell |
1,525
-2,600
| -63% | -$67.4K | ﹤0.01% | 1653 |
|
|
2023
Q3 | $104K | Hold |
4,125
| – | – | ﹤0.01% | 1490 |
|
|
2023
Q2 | $87K | Buy |
4,125
+1,609
| +64% | +$30.5K | ﹤0.01% | 1544 |
|
|
2023
Q1 | $43K | Sell |
2,516
-1,609
| -39% | -$31.3K | ﹤0.01% | 1763 |
|
|
2022
Q4 | $82K | Buy |
4,125
+24
| +0.6% | +$464 | ﹤0.01% | 1621 |
|
|
2022
Q3 | $71K | Buy |
4,101
+86
| +2% | +$2.06K | ﹤0.01% | 1624 |
|
|
2022
Q2 | $79K | Buy |
4,015
+1,110
| +38% | +$23.3K | ﹤0.01% | 1570 |
|
|
2022
Q1 | $68K | Sell |
2,905
-810
| -22% | -$18.8K | ﹤0.01% | 1747 |
|
|
2021
Q4 | $84K | Sell |
3,715
-2,180
| -37% | -$62.3K | ﹤0.01% | 1581 |
|
|
2021
Q3 | $162 | Buy |
5,895
+4,800
| +438% | +$126K | ﹤0.01% | 1489 |
|
|
2021
Q2 | $31 | Sell |
1,095
-3,650
| -77% | -$108K | ﹤0.01% | 2043 |
|
|
2021
Q1 | $162 | Hold |
4,745
| – | – | ﹤0.01% | 1548 |
|
|
2020
Q4 | $158K | Buy |
4,745
+1,150
| +32% | +$42K | ﹤0.01% | 1568 |
|
|
2020
Q3 | $116K | Buy |
3,595
+2,750
| +325% | +$79K | ﹤0.01% | 1498 |
|
|
2020
Q2 | $23K | Buy |
845
+195
| +30% | +$4.62K | ﹤0.01% | 1753 |
|
|
2020
Q1 | $10K | Buy |
650
+50
| +8% | +$1.19K | ﹤0.01% | 1851 |
|
|
2019
Q4 | $14K | Buy |
600
+100
| +20% | +$2.03K | ﹤0.01% | 1762 |
|
|
2019
Q3 | $9K | Hold |
500
| – | – | ﹤0.01% | 1808 |
|
|
2019
Q2 | $13K | Buy |
500
+200
| +67% | +$5.57K | ﹤0.01% | 1689 |
|
|
2019
Q1 | $9K | Sell |
300
-350
| -54% | -$9.07K | ﹤0.01% | 1786 |
|
|
2018
Q4 | $9K | Hold |
650
| – | – | ﹤0.01% | 1675 |
|
|
2018
Q3 | $13K | Hold |
650
| – | – | ﹤0.01% | 1644 |
|
|
2018
Q2 | $15K | Buy |
650
+200
| +44% | +$5.15K | ﹤0.01% | 1598 |
|
|
2018
Q1 | $10K | Sell |
450
-350
| -44% | -$9.21K | ﹤0.01% | 1656 |
|
|
2017
Q4 | $25K | Hold |
800
| – | – | ﹤0.01% | 1503 |
|
|
2017
Q3 | $25K | Hold |
800
| – | – | ﹤0.01% | 1488 |
|
|
2017
Q2 | $14K | Buy |
800
+500
| +167% | +$8.54K | ﹤0.01% | 1596 |
|
|
2017
Q1 | $5K | Sell |
300
-1,500
| -83% | -$23.1K | ﹤0.01% | 1804 |
|
|
2016
Q4 | $24K | Buy |
1,800
+700
| +64% | +$9.55K | ﹤0.01% | 1576 |
|
|
2016
Q3 | $16K | Hold |
1,100
| – | – | ﹤0.01% | 1717 |
|
|
2016
Q2 | $11K | Hold |
1,100
| – | – | ﹤0.01% | 1776 |
|
|
2016
Q1 | $14K | Buy |
+1,100
| New | +$14.5K | ﹤0.01% | 1710 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Nisa Investment Advisors's INSM Position: Q1 2026 in Review
Nisa Investment Advisors reduced its Insmed (INSM) stake by 23% in Q1 2026, selling an estimated $630K and leaving 13,447 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #589.
Nisa Investment Advisors first reported a position in INSM in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.05M in Q4 2025. 672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Nisa Investment Advisors held 13,447 shares of Insmed worth $2.2M as of Q1 2026.
- Nisa Investment Advisors sold 4,095 Insmed shares in Q1 2026, an estimated $630K.
- Insmed made up 0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #589 holding.
- Nisa Investment Advisors first reported a position in Insmed in Q1 2016 and has held it in 41 quarters since.
- Nisa Investment Advisors's Insmed position peaked at $3.05M in Q4 2025.
- 672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.